DCPH – deciphera pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
6/11
08:38 am
dcph
Neutral
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) [Yahoo! Finance]
6/11
08:30 am
dcph
Neutral
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)
6/3
07:08 am
dcph
Low
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet [Yahoo! Finance]
6/3
07:00 am
dcph
Neutral
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet
5/30
08:06 am
dcph
Low
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
5/10/2024
07:27 am
dcph
0.4%
BEAT
2/6/2024
07:00 am
dcph
-1.8%
BEAT
10/30/2023
07:01 am
dcph
17.5%
BEAT
8/9/2023
07:00 am
dcph
4.1%
BEAT
4/30
01:19 pm
Reiterates
Buy
Neutral
Guggenheim
Low
-0.2%
4/30
01:19 pm
Reiterates
Buy
Neutral
Guggenheim
Low
-0.2%
4/30
01:01 pm
Downgrades
Buy
Neutral
Guggenheim
Low
-0.2%
4/30
01:01 pm
Downgrades
Buy
Neutral
Guggenheim
Low
-0.2%
4/30
12:10 pm
Reiterates
Market Outperform
Market Perform
JMP Securities
Low
-0.3%
6/11
09:02 pm
dcph
Neutral
Form 4 Deciphera Pharmaceutical For: Jun 11 Filed by: Sherman Matthew L
6/11
08:56 pm
dcph
Neutral
Form 4 Deciphera Pharmaceutical For: Jun 11 Filed by: Kelly Thomas Patrick
6/11
08:52 pm
dcph
Neutral
Form 4 Deciphera Pharmaceutical For: Jun 11 Filed by: Pitman Jama
6/11
08:49 pm
dcph
Neutral
Form 4 Deciphera Pharmaceutical For: Jun 11 Filed by: Friedman Franklin Stuart
6/11
08:47 pm
dcph
Neutral
Form 4 Deciphera Pharmaceutical For: Jun 11 Filed by: Kelley Susan L.
Show more
Top News Gainers
8/13 Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors 79.9%
4/28 Deciphera Pharmaceuticals, Inc. to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 5, 2020 14.7%
4/3 Form 4 Deciphera Pharmaceutical For: Apr 01 Filed by: Taylor Michael Douglas 14.0%
4/16 Form 4 Deciphera Pharmaceutical For: Apr 14 Filed by: Taylor Michael Douglas 8.6%
1/9 Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.5%
10/28 Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 4, 2019 8.3%
10/29 Form 8-K Deciphera Pharmaceutical For: Oct 28 8.2%
6/3 Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) had its price target raised by analysts at Piper Jaffray Companies from $50.00 to $55.00. They now have an "overweight" rating on the stock. 7.2%
3/2 Deciphera Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call and Webcast on March 9, 2020 7.1%
3/9 Q4/2019 12/31/2019 EPS -1.310 ZacksConsensus -1.130 ActVsEst (0.180) - Miss 5.9%
Top News Decliners
8/13 Deciphera's late-stage study meets main goal of preventing cancer progression [Reuters (UK)] -20.2%
3/14 Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -19.0%
2/12 Form S-3ASR Deciphera Pharmaceutical -17.4%
4/30 Form 4 Deciphera Pharmaceutical For: Apr 28 Filed by: Taylor Michael Douglas -9.7%
6/21 Form 4 Deciphera Pharmaceutical For: Jun 19 Filed by: Kelly Thomas Patrick -9.0%
6/13 Form 4 Deciphera Pharmaceutical For: Jun 11 Filed by: Benz Edward J. JR -7.4%
5/9 Q1/2019 3/31/2019 EPS -1.250 ZacksConsensus -0.790 ActVsEst (0.460) - Miss -5.4%
11/26 Form 3 Deciphera Pharmaceutical For: Nov 25 Filed by: Friedman Franklin Stuart -5.2%
8/14 Form S-3MEF Deciphera Pharmaceutical -4.9%
12/26 Form 4 Deciphera Pharmaceutical For: Dec 23 Filed by: Kelly Thomas Patrick -4.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3